Wen-Jie Tan

Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety

Beijing

China

SCHOLARLY PAPERS

2

DOWNLOADS

488

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 447 (98,662)

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

2.

Kinetics and Factors Associated With 12-Month Persistence of Neutralizing Antibody Induced by Two Inactivated COVID-19 Vaccines

Number of pages: 18 Posted: 24 Mar 2022
Harbin Medical University - Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Zhejiang Provincial Center for Disease Control and Prevention, affiliation not provided to SSRN, affiliation not provided to SSRN, Harbin Medical University - Chinese Center for Disease Control and Prevention, Harbin Medical University - Chinese Center for Disease Control and Prevention, Harbin Medical University - Chinese Center for Disease Control and Prevention, Harbin Medical University - Chinese Center for Disease Control and Prevention, Harbin Medical University - Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Immunization Program, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Institute for Viral Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Institute for Viral Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Institute for Viral Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Institute for Viral Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Harbin Medical University - Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Institute for Viral Disease Control and Prevention, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Immunization Program and Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety
Downloads 41 (620,524)

Abstract:

Loading...